The Biostatistics Core (BC) provides expertise in biostatistics, clinical trials, and experimental design, as wellas supporting electronic data management for clinical research. Scientific consultation is provided by facultystatisticians who collaborate in the development of pilot projects, grant proposals and clinical protocols. TheBC statisticians help design research studies, and conduct interim and final data analyses. Core servicesinclude the development of case-report forms, databases and data entry tools to initiate clinical protocols, aswell as access to clinical research and cancer registry data repositories for retrospective research. The Coreprovides expertise and access to a variety of technologies, including modern statistical computingenvironments such as SAS, JMP, Splus, and R; specialized statistical computing tools for microarrays,genetic linkage and association studies, and pharmacokinetics; tools to implement scannable forms andelectronic data capture; web portals for data entry and study monitoring; and a centralized MS SQL-serverdatabase for clinical research. Service to the institution includes statistical review of cancer-related clinicalresearch protocols. The core is directed by Jeffrey Longmate, PhD, Director of the Department ofBiostatistics. Co-Director is Joyce Niland, PhD, Director of the Clinical Protocol Management Core. The staffof the BC includes a large part of the department, and the BC enables their participation in Cancer Centerrelatedpilot projects and proposals, which may later develop into externally funded projects. The BC isdirectly involved in Cancer Center research from the inception of a research idea to the publication of results.The BC focuses heavily on clinical research, but also supports basic and translational research, as well assupporting several other cores. The BC collaborates continually with the Biomedical Informatics Core tooperate and further develop the MIDAS clinical research database, and regularly collaborates with membersof the Clinical Protocol Management Core to implement City of Hope-conducted or coordinated clinicalprotocols. In 2005, the BC was used by 80 CC members from all Programs, and logged 204 projects,including 21 grants naming BC personnel (7 multi-project grants), and 32 clinical protocols newly openedwith BC collaboration. Annual budget for the core is $2,651,640, with 62% from the institution, 34% othersources, and 4% ($100,100) requested from the CCSG.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA033572-25
Application #
7714130
Study Section
Subcommittee G - Education (NCI)
Project Start
2008-09-01
Project End
2012-11-30
Budget Start
2008-09-01
Budget End
2008-11-30
Support Year
25
Fiscal Year
2008
Total Cost
$71,000
Indirect Cost
Name
City of Hope/Beckman Research Institute
Department
Type
DUNS #
027176833
City
Duarte
State
CA
Country
United States
Zip Code
91010
Querfeld, Christiane; Leung, Samantha; Myskowski, Patricia L et al. (2018) Primary T Cells from Cutaneous T-cell Lymphoma Skin Explants Display an Exhausted Immune Checkpoint Profile. Cancer Immunol Res 6:900-909
Liu, Xuxiang; Cao, Minghui; Palomares, Melanie et al. (2018) Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts. Breast Cancer Res 20:127
Das, Sadhan; Reddy, Marpadga A; Senapati, Parijat et al. (2018) Diabetes Mellitus-Induced Long Noncoding RNA Dnm3os Regulates Macrophage Functions and Inflammation via Nuclear Mechanisms. Arterioscler Thromb Vasc Biol 38:1806-1820
Al Malki, Monzr M; Nathwani, Nitya; Yang, Dongyun et al. (2018) Melphalan-Based Reduced-Intensity Conditioning is Associated with Favorable Disease Control and Acceptable Toxicities in Patients Older Than 70 with Hematologic Malignancies Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 24:1828-1835
Chiuppesi, Flavia; Nguyen, Jenny; Park, Soojin et al. (2018) Multiantigenic Modified Vaccinia Virus Ankara Vaccine Vectors To Elicit Potent Humoral and Cellular Immune Reponses against Human Cytomegalovirus in Mice. J Virol 92:
Petrossian, Karineh; Kanaya, Noriko; Lo, Chiao et al. (2018) ER?-mediated cell cycle progression is an important requisite for CDK4/6 inhibitor response in HR+ breast cancer. Oncotarget 9:27736-27751
Ambaye, Nigus; Chen, Chih-Hong; Khanna, Swati et al. (2018) Streptonigrin Inhibits SENP1 and Reduces the Protein Level of Hypoxia-Inducible Factor 1? (HIF1?) in Cells. Biochemistry 57:1807-1813
Bosworth, Alysia; Goodman, Elizabeth L; Wu, Eric et al. (2018) The Minneapolis-Manchester Quality of Life Instrument: reliability and validity of the Adult Form in cancer survivors. Qual Life Res 27:321-332
Vu, Binh Thanh; Shahin, Sophia Allaf; Croissant, Jonas et al. (2018) Chick chorioallantoic membrane assay as an in vivo model to study the effect of nanoparticle-based anticancer drugs in ovarian cancer. Sci Rep 8:8524
Yan, Wei; Wu, Xiwei; Zhou, Weiying et al. (2018) Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells. Nat Cell Biol 20:597-609

Showing the most recent 10 out of 1396 publications